The data were obtained from the Manchester Imaging Study, a prospective study on the role of imaging technologies in the diagnosis and management of glaucoma. The study was performed at the Manchester Royal Eye Hospital (MREH) from 1998 to 2004 and included both cross-sectional and longitudinal arms.
8 It adhered to the tenets of the Declaration of Helsinki and was approved by the Central Manchester Research Ethics Committee. Informed written consent was obtained from all participants.
The patients with glaucoma were consecutively recruited from the clinics at the MREH. Inclusion criteria were a clinical diagnosis of open-angle glaucoma, age >40 years, refractive error within ±5.00 D equivalent sphere and ±3.00 D astigmatism, best corrected visual acuity (VA) of 6/18 (+0.5 logMAR; logarithm of the minimum angle of resolution), and a repeatably detectable visual field defect. Visual fields were examined using program 24-2 of the Humphrey Field Analyzer (HFA; Carl Zeiss Meditec, Dublin, CA) with the full–threshold strategy, and a defect was defined as a glaucoma hemifield test (GHT) result outside normal limits and/or a corrected pattern standard deviation (CPSD) significantly elevated beyond the 5% level. For the analyses reported herein, eyes with mean deviation [MD] worse than −10 dB were excluded. If both eyes were eligible, one eye was randomly selected as the study eye. Of those patients who participated in the longitudinal arm of the study, we selected the image in which the mean pixel height standard deviation (MPHSD), a measure of image quality, was closest to the median value observed during the entire follow-up; thus, we analyzed the most representative image of the available series. Three patients and three healthy control subjects were removed from the analysis because their median MPHSD exceeded 50 μm, the recommended cutoff for image quality (HRT user manual; Heidelberg Engineering GmbH). Normal control subjects were recruited from patients’ spouses and by advertising through leaflets and posters distributed in local medical centers, universities, and other communal areas. Inclusion criteria were age >40 years, intraocular pressure below 22 mm Hg, refractive error within ±5.00 D equivalent sphere and ± 3.00 D astigmatism, best corrected VA of 6/18 (+0.5 logMAR), and normal findings in a visual field examination (HFA 24-2 full-threshold test, both CPSD >10% and GHT results within normal limits).